Health Innovation Catalyst
Virtual, On-Demand Platform for Science-Based Alcohol Therapy
LIVE ▶ Complete free digital visit and connect to verified therapy-informed providers and vetted therapy companions.
Virtual, On-Demand Platform for Revolutionary Alcohol Therapy
LIVE ▶ Compete free digital visit and match with verified therapy-informed providers and vetted therapy companions.
Virtual, On-Demand Platform for Revolutionary Alcohol Therapy
LIVE ▶ Compete digital visit and match with verified therapy-informed providers and vetted therapy companions.
Once viewed as a chronic, incurable brain disease manageable only through withdrawal and abstinence, alcohol disorder is now understood differently through neurophysiological discoveries. Research shows it can be reversed through pharmacological extinction therapy. Developed by Dr. John David Sinclair (1942-2014), this protocol has demonstrated 78-93% long-term success rates by leveraging the nervous system's natural ability to eliminate learned behaviours reinforced by endorphin release.
Once misunderstood as a chronic, incurable brain disease that could only, at best, be managed with withdrawal and sobriety, neurophysiological research now shows that alcohol use disorder can be totally reversed through pharmacological extinction therapy (PET). Developed by John David Sinclair, and also known as The Sinclair Method, this therapy boasts a 78-93% long-term success rate. It’s based on the nervous system’s natural ability to form and eliminate reflexive cravings for behaviours that were repeatedly reinforced by the release of endorphins.
Over 120+
Validating Studies
Virtual, On-Demand Platform for Science-Based Alcohol Therapy
LIVE ▶ Compete free digital visit and match with verified therapy-informed providers and vetted therapy companions.
Free | Online | 5 minutes
Health Innovation Catalyst
Digital Visit
Complete a free virtual visit exploring your medical history and desirable outcomes. All data is encrypted, securely stored, and never shared without your consent.
Eligibility Assessment
Our engine analyses your responses to evaluate potential eligibility for the treatment. Please note, the results is not a diagnosis, and for informational purpose only,
Matching with Provider
Select your medical partner from a directory of licensed providers, experienced in the protocol, to schedule an online consultation for your therapeutic journey plan.
Tailored Treatment
If prescribed, get medication discreetly from the pharmacy of your choice. Benefit from ongoing guidance throughout your journey through chat with the doctor.
Protecting Receptors
Protecting Receptors
With Safe Medication
With Safe Medication
One Dose Prior Drinking
One Dose Prior Drinking
Nervious System Response
Nervious System Response
Eliminating Cravings
Eliminating Cravings
🔬 Pharmacological Extinction Therapy: scientific evidence and clinical practice.
🔬Understanding
Pharmacological Extinction
PET, or The Sinclair Method, is a neuroscience-based approach using targeted pharmacotherapy to gradually eliminate cravings and naturally reduce alcohol intake, without the need for abrupt quitting.
PET, or The Sinclair Method, is a neuroscience-based approach using targeted pharmacotherapy to gradually eliminate cravings and naturally reduce alcohol intake, without the need for abrupt quitting.
TSM
Funded by a state program in Finland, Dr. John David Sinclair, through decades of research, combined Pavlov's principles of conditioned learning with targeted pharmacotherapy to create The Sinclair Method (TSM). The nervous system learns to associate endorphin-releasing activities as beneficial, developing reflexive cravings that intensify over time and become difficult to control — this condition is known as Alcohol Use Disorder.
Pharmacological extinction rewires the nervous system’s conditioned inclination toward alcohol, resulting in a natural loss of interest in drinking. Clinically proven with a 78-93% success rate in 120+ studies and nationwide implementation in Finland, TSM is now available globally following patent expiration. Best of all, it can be administered virtually, ensuring convenient, discreet access for anyone in need. And that's where Curada comes in.
Dr. J.D. Sinclair
Neuroscientist
Prof. Ivan Pavlov
Physiologist
TSM
Funded by a state program in Finland, Dr. John David Sinclair, through decades of research, combined Pavlov's principles of conditioned learning with targeted pharmacotherapy to create The Sinclair Method (TSM). The nervous system learns to associate endorphin-releasing activities as beneficial, developing reflexive cravings that intensify over time and become difficult to control — this condition is known as Alcohol Use Disorder.
Pharmacological extinction rewires the nervous system’s conditioned inclination toward alcohol, resulting in a natural loss of interest in drinking. Clinically proven with a 78-93% success rate in 120+ studies and nationwide implementation in Finland, TSM is now available globally following patent expiration. Best of all, it can be administered virtually, ensuring convenient, discreet access for anyone in need. And that's where Curada comes in.
Dr. J.D. Sinclair
Neuroscientist
Prof. Ivan Pavlov
Neurologist
TSM
Funded by a state program in Finland, Dr. John David Sinclair, through decades of research, combined Pavlov's principles of conditioned learning with targeted pharmacotherapy to create The Sinclair Method (TSM). The nervous system learns to associate endorphin-releasing activities as beneficial, developing reflexive cravings that intensify over time and become difficult to control — this condition is known as Alcohol Use Disorder.
Pharmacological extinction rewires the nervous system’s conditioned inclination toward alcohol, resulting in a natural loss of interest in drinking. Clinically proven with a 78-93% success rate in 120+ studies and nationwide implementation in Finland, TSM is now available globally following patent expiration. Best of all, it can be administered virtually, ensuring convenient, discreet access for anyone in need. And that's where Curada comes in.
Dr. J.D. Sinclair
Neuroscientist
Prof. Ivan Pavlov
Neurologist
TSM
Funded by a state program in Finland, Dr. John David Sinclair, through decades of research, combined Pavlov's principles of conditioned learning with targeted pharmacotherapy to create The Sinclair Method (TSM). The nervous system learns to associate endorphin-releasing activities as beneficial, developing reflexive cravings that intensify over time and become difficult to control — this condition is known as Alcohol Use Disorder.
Pharmacological extinction rewires the nervous system’s conditioned inclination toward alcohol, resulting in a natural loss of interest in drinking. Clinically proven with a 78-93% success rate in 120+ studies and nationwide implementation in Finland, TSM is now available globally following patent expiration. Best of all, it can be administered virtually, ensuring convenient, discreet access for anyone in need. And that's where Curada comes in.
Dr. J.D. Sinclair
Neuroscientist
Prof. Ivan Pavlov
Physiologist
Virtual Health Hub
Therapy Checkpoints
Telehealth Concierge
🩺 Partner with Curada to Deliver Cutting-Edge Therapy
🩺 Partner with Curada to Deliver Next-Gen Therapy
We believe that technology has the power to dramatically expand access to medical breakthroughs, enabling forward-thinking providers to deliver these innovative treatments more effectively through therapy-specific digital infrastructure
Continuity of Care
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Secure Technology
Our platform ensures that data security, storage, and management fully comply with healthcare regulations and legal requirements, providing peace of mind for both providers and patients.
Therapy-Specific Software
With a user-centered approach, our goal is to create an intuitive interface for convenient therapy management, incorporating best engagement practices such as gamification and social rewards.
Therapy-Specific Software
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Secure Technology
Our platform ensures that data security, storage, and management fully comply with healthcare regulations and legal requirements, providing peace of mind for both providers and patients.
Continuity of Care
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Therapy-Specific Software
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Secure Technology
Our platform ensures that data security, storage, and management fully comply with healthcare regulations and legal requirements, providing peace of mind for both providers and patients.
Continuity of Care
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Continuity of Care
We combine provider involvement with technology automation and curated peer support, optimizing provider resources and enhancing the delivery of the therapy protocol.
Secure Technology
Our platform ensures that data security, storage, and management fully comply with healthcare regulations and legal requirements, providing peace of mind for both providers and patients.
Therapy-Specific Software
With a user-centered approach, our goal is to create an intuitive interface for convenient therapy management, incorporating best engagement practices such as gamification and social rewards.